Instructions for use
Calmark POC - Neo
IFU_Calmark_Neo_3-55004-EN_107
15 (15)
Test cassette
Width
23.2 mm
Depth
8.7 mm
Height
42.1 mm
Weight
Approx. 2.79 g
Instrument
Width
120 mm
Depth
210 mm
Height
93 mm
Weight
Approx. 900 g
17.14
P
ERFORMANCE SPECIFICATION
Time to result
2 minutes
Detection range
150-500 µmol/L (9-29 mg/dL)
Bilirubin <150 µmol/L
(<9 mg/dL)
CV 6.9%
Bilirubin between 150 and 500 µmol/L
(9-29 mg/dL) CV 5.2%
Bilirubin > 500 µmol/L
(>29 mg/dL)
CV 4.4%
Interference levels
No interference with hemolysis in
samples up to 2 g/L
Sample hematocrit
Handles samples with hematocrit up
to 60%
Anticoagulants interference
The product can handle up to 18 U/L
lithium heparin and 12 mg/L EDTA
Number of stored results in archive
25 results stored locally
18
R
EFERENCES
1.
Pace, E. J., Brown, C. M., & DeGeorge, K. C. Neonatal hyperbilirubinemia: An evidence- based
approach. The journal of family practice. 2019;
68(1):
E4-E11.
2.
Evans, D. Neonatal Jaundice. Clinical Evidence 20016;15: 1-6. BMJ Publishing Group Ltd.
3.
Norman, M. Bilirubinskador bland nyfödda kan förhindras: nya verktyg håller nollvisionen vid
liv. Läkartidningen 2006; 103(26-27): 2032-2033.